SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (5069)12/6/2001 9:26:56 AM
From: Biomaven  Read Replies (2) | Respond to of 52153
 
Interesting - another short favorite (CORR) gets munched. If PCYC comes up with a decent Phase III (I give this one 60:40 odds) the shorts will have had a pretty miserable December on top of a pretty bad October/November period.

I'll comment on the deal itself over in the Munch thread.

Peter



To: IRWIN JAMES FRANKEL who wrote (5069)12/6/2001 9:28:31 AM
From: jayhawk969  Respond to of 52153
 
&

COR had about $633 million in cash and cash equivalents as of Sept. 30.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News